CLDX Market Cap & Key Metrics
Celldex Therapeutics, Inc.
$28.51
+$0.67(+2.42%)
35
Overall
60
Value
18
Tech
28
Quality
Market Cap
$2.19B
Volume
212.09K
52W Range
$22.10 - $45.14
Target Price
$63.29
CLDX market cap is $2.19B. This page lists Celldex Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CLDX Key Metrics
- Market cap
- $2.19B
- EPS estimate, current year
- $-4.17
- EPS growth, 3-year
- -17.57%
- Value score
- 60
- Quality score
- 28
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.54M | $7.02M | $6.88M | $2.36M | $4.65M |
| EBITDA | -$255.08M | -$170.06M | -$152.11M | -$126.91M | -$66.08M |
| EPS | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $28.51 | +2.4% | 212.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW